Buscar
Mostrando ítems 21-30 de 247
Adrenal function status in patients with Paracoccidioidomycosis after prolongued post-therapy follow-up
(American Society of Tropical Medicine and HygieneMicología Médica y ExperimentalBaltimore, Estados Unidos, 2021)
Hormone replacement therapy in menopause as a risk factor for developing breast cancer
(Universidade Federal do Estado do Rio de Janeiro Escola de Enfermagem Alfredo Pinto Programa de Pós-Graduação em Enfermagem, 2014)
Estrógenos, envejecimiento y enfermedad de AlzheimerEstrogens, aging and alzheimer’s disease
(Universidad de Antioquia, Facultad de MedicinaBiología Celular y Molecular CIB, U. de A. U. del RosarioMedellín, Colombia, 2021)
Hormone therapy for the artificial control of sexual maturity infish culture: a reviewARCHIVOS DE MEDICINA VETERINARIAArch. Med. Vet.
(UNIV AUSTRAL CHILE, FAC CIENCIAS VETERINARIAS, 2017)
Causas de abandono, cambio o fallo terapéutico de la anticoncepción hormonal en mujeres universitariasCauses of dropout, change or therapeutic failure to hormonal contraception in university women
(Universidad CES, Facultad de MedicinaPromoción y Prevención FarmacéuticaMedellín, Colombia, 2021)
Skeletal maturation in intrauterine growth-retarded rats treated with growth hormone
(I R O G Canada, Inc, 2004-06)
The objective of this study was to analyse the effects of intrauterine growth retardation (IUGR) and growth hormone (Gh) therapy on skeletal maturation in growth retarded rats. One-hundred and thirty-five rats constituted ...
Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models
(Springer, 2016-08)
[V4Q5]dDAVP is a novel 2nd generation vasopressin analogue with robust antitumour activity against metastatic breast cancer. We recently reported that, by acting on vasopressin V2r membrane receptor present in tumour cells ...